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Acquired immunity against infectious disease (AIID) has long been considered as
strictly dependent on the B and T lymphocytes of the adaptive immune system.
Consequently, AIID has been viewed as highly specific to the antigens expressed by
pathogens. However, a growing body of data motivates revision of this central paradigm
of immunology. Unrelated past infection, vaccination, and chronic infection have been
found to induce cross-protection against numerous pathogens. These observations
can be partially explained by the poly-specificity of antigenic T and B receptors, the
Mackaness effect and trained immunity. In addition, numerous studies highlight the
importance of microbiota composition on resistance to infectious disease via direct
competition or modulation of the immune response. All of these data support the idea that
a non-negligible part of AIID in nature can be nonspecific to the pathogens encountered
and even of the antigens expressed by pathogens. As this protection may be dependent
on the private T and B repertoires produced by the random rearrangement of genes, past
immune history, chronic infection, and microbiota composition, it is largely unpredictable
at the individual level. However, we can reasonably expect that a better understanding
of the underlying mechanisms will allow us to statistically predict cross-protection at the
population level. From an evolutionary perspective, selection of immune mechanisms
allowing for partially nonspecific AIID would appear to be advantageous against highly
polymorphic and rapidly evolving pathogens. This new emerging paradigm may have
several important consequences on our understanding of individual infectious disease
susceptibility and our conception of tolerance, vaccination and therapeutic strategies
against infection and cancer. It also underscores the importance of viewing themicrobiota
and persisting infectious agents as integral parts of the immune system.
Keywords: infectious diseases, microbiota, acquired immunity, cross-protection, heterologous immunity,
mackaness effect, trained immunity, nonspecific effects of vaccines
ACQUIRED IMMUNITY AGAINST INFECTIOUS DISEASE
Long ago, physicians observed that people who had recovered from the plague never got it
again and displayed “acquired immunity” against infectious disease (AIID). Early vaccination
techniques developed by Jenner were based on these observations and immunology stemmed,
in large part, from the necessity to understand how vaccines work in order to improve their
efficacy and their safety. For decades, AIID has been explained to immunology students as strictly
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dependent on the adaptive immune system composed of B and
T lymphocytes expressing highly specific antigenic receptors.
As a result, the development of vaccines has been closely
linked to the identification of immunodominant antigens
expressed by pathogens, with vaccination being presented
as an infectious disease-specific intervention. However, a
growing body of data from epidemiology, vaccinology, and
experimental immunology research supports the idea that AIID
can also be frequently nonspecific to the antigens expressed
by pathogens. Depending on the case, this phenomenon has
been explained by (i) cross-protection induced by vaccination
or past infection, (ii) the “Mackaness effect” resulting from
unrelated chronic infection, and (iii) microbiota-mediated
protection.
Nonspecific Protective Effects of
Vaccination
Numerous epidemiological and experimental studies have
reported that previous exposure to unrelated infectious agents
can greatly alter the host’s immune response to an infection
and induce a state of protective immunity, frequently termed
“heterologous immunity” (reviewed in Welsh and Selin, 2002;
Selin et al., 2011; Benn et al., 2013; Aaby et al., 2014). For
example, epidemiological studies have shown that individuals
vaccinated with vaccinia virus were less susceptible to infectious
diseases such as measles, scarlet fever, whooping cough, and
syphilis when compared to non-vaccinated persons (Mayr, 2004).
In experimental studies, BCG vaccination protected not only
against mycobacteria, but also against secondary infections
with Listeria monocytogenes (Blanden et al., 1969), Salmonella
typhimurium (Blanden et al., 1969), Staphylococcus aureus
(Sher et al., 1975), Candida albicans (Sher et al., 1975; Van’t
Wout et al., 1992), Plasmodium yoelii (Matsumoto et al., 2000;
Parra et al., 2013), and Schistosoma mansoni (Tribouley et al.,
1978). Of course, nonspecific vaccine effects are not always
positive. For example, while the diphtheria-tetanus-pertussis
(DTP) vaccine protects against the three targeted diseases,
it has been documented to increase female mortality from
other infectious diseases (Aaby et al., 2012). The mechanisms
underlying this negative effect are still unknown and remain
to be investigated. On the whole, these data suggest that, in
addition to their antigen- or target-specific effects, live vaccines
“have nonspecific effects that may be just as important, or
even more important” (Benn et al., 2013). As expected, similar
experimental observations have been made with non-attenuated,
fully virulent pathogens. For example, memory cytotoxic CD8+
T lymphocytes induced by lymphocytic choriomeningitis virus
(LCMV) infection are reactivated by the Pichinde virus and
vaccinia virus, demonstrating that prior immunity to a specific
virus could modulate future primary immune responses to a
second, unrelated virus (Selin et al., 1994). We should also note
that a comparison of homologous and heterologous protection
showed that heterologous protection was generally considerably
less than the almost total protection seen after challenge
with a homologous infectious agent (Frenkel and Caldwell,
1975).
Chronic Infection and the “Mackaness
Effect”
Research has long neglected the study of “slow infection”
(associated with a long incubation period) and chronic
infection by stealth or silent pathogens, such as herpesviruses,
cytomegalovirus, Brucella, and Bartonella,which are the causative
agents of several under-diagnosed chronic diseases constituting
the most common infectious diseases. However, it has now
become clear that persistence of a pathogen, even at very low
levels, can affect the ability of the immune system to react to
a new unrelated infection (reviewed in Stelekati and Wherry,
2012). Chronic infection can reduce or enhance the ability
to control unrelated pathogens, a phenomenon termed the
“Mackaness effect” in reference to the seminal work ofMackaness
(Mackaness, 1964; Blanden et al., 1969) in 1964 demonstrating
cross-protection between L. monocytogenes, Brucella abortus
and Mycobacterium tuberculosis in mice (see Figure 1). More
recent studies showed that herpes virus infection can confer
beneficial protection against L. monocytogenes and Yersinia
pestis (Barton et al., 2007), Helicobacter pylori infection is
associated with protection against tuberculosis (Perry et al., 2010)
and cytomegalovirus infection enhances the immune response
to influenza vaccination (Furman et al., 2015). The precise
molecular mechanisms involved in the Mackaness effect have yet
to be elucidated. However, some aspects of the innate immune
response, such as polarization of macrophages (Potian et al.,
2011), stable histone changes in innate immune effector cells
(epigenetic reprogramming) (Kleinnijenhuis et al., 2012) and
nutritional immunity (Nairz et al., 2010; Cassat and Skaar, 2013),
may account for the protective effect of chronic infection.
Microbiota-Mediated Protection Against
Infection
Microbes colonize mammalian hosts immediately after birth,
forming a resident-specific microbial community including
bacteria, fungi, and viruses. This is referred to as the
“microbiota.” Numerous authors (Kitano and Oda, 2006; Cerf-
Bensussan and Gaboriau-Routhiau, 2010) have proposed that
the microbiota can be considered as an integral part of the
immune system. In support of this view, it is well known that
germ-free mice are highly susceptible to infection (reviewed
in Cerf-Bensussan and Gaboriau-Routhiau, 2010) and that the
microbiota is required for adequate immune system maturation
(Ivanov et al., 2009; Buffie and Pamer, 2013) and can contribute
to the control of infectious microorganisms (Ivanov et al.,
2009; Buffie and Pamer, 2013; Kamada et al., 2013). How the
microbiota prevents pathogen colonization has been studied
for many years, and the mechanisms involved largely fall into
two categories: direct interactions between the microbiota and
pathogens (competition-mediated colonization protection) and
microbiota-mediated enhancement of host defense mechanisms
(immune-mediated colonization protection). Themicrobiota can
compete with pathogens to acquire nutrients, produce toxic
compounds such as H2O2 or target structures that mediate
adherence to the epithelium of the competing microorganism
(reviewed in Bosch et al., 2013). Themicrobiota can also affect the
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FIGURE 1 | Integrated view of the impact of past infection, chronic pathogen infection, and the microbiota on new invading pathogens.
responsiveness of the innate immune system (Wang et al., 2013),
induce a cross-reacting immune repertoire able to recognize
pathogens (reviewed in Buffie and Pamer, 2013) and favor the
persistence of peripheral memory T cells (Tanaka et al., 2007),
probably via cross-reactivity between the antigens recognized by
memory T cells and the variety of antigens derived from the
members of the microbiota. Systematic studies of the dynamic
interactions between the microbiota and pathogens at the host
mucosal surface could help develop predictive models of cross-
protection (Bosch et al., 2013).
THE NONSPECIFIC SIDE OF THE
ADAPTIVE IMMUNE RESPONSE
All of the data discussed above indicate that the efficiency of the
individual immune response to fight infectious microorganisms
is largely dependent on endogenous (mutualistic and parasitic)
microorganisms and the past immune history of the host
(Figure 1). Recent discoveries regarding the poly-specificity of
antigenic receptors, the important role of innate immune cells in
regulation of the adaptive response and trained immunity have
provided a better understanding of the underlying mechanisms
of cross-protection.
The “Poly-Specificity” of B and T
Lymphocytes
The “clonal selection hypothesis” developed by Jerne in 1954,
which is based on the “Lock and Key” model of Emil
Fischer, proposes that each lymphocyte bears a single type of
antigen receptor with unique specificity (the “one clonotype–
one specificity” paradigm). Under that theory, stimulation
of this receptor is required for activation of the cell and
entrance of an antigen into the body results in the selection
of only a few B lymphocytes that recognize the antigen and
produce a corresponding antibody to destroy it. However, since
this pioneering time, the “poly-specificity” (also termed poly-
reactivity, plasticity or degeneracy) of B cell receptor (BCR) and
T cell receptor (TCR) [functionally the ability of a single receptor
to specifically recognize many different antigens, as discussed
in (Wucherpfennig et al., 2007)] has been well documented
[reviewed in (Notkins, 2004) for BCRs and in (Wucherpfennig,
2004; Eisen and Chakraborty, 2010; Sewell, 2012) for TCRs].
Poly-specificity of the BCR has been mostly observed with
natural antibodies, such as IgM in particular, that dominate
the newborn B cell repertoire (Chen et al., 1998). Poly-specific
BCRs bind to self-antigens as well as to a variety of bacteria and
viruses (Oldstone, 2014), suggesting that they may be involved
in preventing the dissemination of pathogens. Their biological
importance has been demonstrated in antibody-deficient mice,
which can be protected against lethal infections via the transfer
of serum from antibody-competent naive animals (Ochsenbein
et al., 1999; Jayasekera et al., 2007; Zola et al., 2009). Concerning
the TCR, it has been estimated, for example, that a single patient-
derived autoimmune CD8 T cell clone recognizes over one
million distinct decamer peptides in the context of a single MHC
class I molecule (Wooldridge et al., 2012). As discussed by the
authors, the poly-specificity of TCRs appears to be crucial for
the interaction of an individual’s limited TCR repertoire (<108
T cell clones) with the >1015 peptide MHC constituting the
vast array of different potential ligands. Experiments have shown
that peptides do not necessarily need to show high sequence
homology to cross-react with the same T cell (Joshi et al., 2001).
Consequently, even the injection of a specific (purified and well
defined) antigen can induce the activation and expansion of a
lymphocyte population able to potentially interact with more
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than just the antigen itself. As the reactivity of this population
is not easy to predict, it is no longer appropriate to use the
term “specific” (in the meaning of “definite” or “precise”) to
describe the immune response induced by a specific antigen. In
addition, the physiological state of memory T cells is such that
they are primed for activation, and they have been observed to
be productively stimulated by a peptide concentration that is 50
times lower than the one required for the stimulation of naive
T cells (Curtsinger et al., 1998). So, it would not be surprising if
a memory T cell could be stimulated by a cross-reactive peptide
with substantially lower affinity for the TCR than the “original”
peptide that created the memory T-cell pool. A theoretical
study suggests that although cross-reactivity is a rare event
for immunologically naive individuals, the probability of cross-
reactive memory T cells becomes very high following successive
infections (Zarnitsyna et al., 2013). B and T lymphocytes also
express a great number of pattern recognition receptors (PRRs),
such as Toll-like receptors (TLRs), that are able to interact
with microbial associated structures or stress-induced molecules
and induce or modulate their activation (Rawlings et al., 2012).
Polyclonal stimulation by a microbial product such as CpG DNA
may participate in the long-term maintenance of memory B cells
(Bernasconi et al., 2002). Bystander infections can also promote
optimal memory T cell responses by providing inflammatory
signals such as IL-15 that are critical for the rapid proliferation
of memory CD8+ T cells (Richer et al., 2015). A recent study
showed that inflammatory monocyte-derived IL-15 and IL-18
can activate memory CD8+ T cells in a bystander manner in
the apparent absence of TCR ligation (Soudja et al., 2012). In
summary, an accumulating mass of evidence demonstrates that
lymphocyte activation via antigen receptors may also not be
“exquisitely antigen-specific” (Alberts et al., 2002) as previously
considered and could furthermore be dependent on nonspecific
innate immune receptors.
Orchestration of the Immune Response
The metaphor by which lymphocytes act as a conductor
orchestrating the immune response has been used widely. This
idea progressively changed at the end of the twentieth century
when immunologists fully realized the crucial role of nonspecific
innate immunity in regulating lymphocyte activity and the
immune response. In fact, a growing body of data suggests
that stromal cells, innate immune cells and “non-conventional”
lymphocytes, such as γδT cells, natural killer T (NKT) cells,
and B1 lymphocytes, play an important role in regulation of
both the primary and memory immune response to infectious
agents (reviewed in Degli-Esposti and Smyth, 2005; Mueller and
Germain, 2009; Bonneville et al., 2010). These non-conventional
lymphocytes usually display low specificity and frequently appear
to be pre-selected to recognize pathogen-associated molecular
patterns (PAMPs). γδT cells recognize a plethora of factors
induced by stress conditions, few of which are characterized
(Bonneville et al., 2010). NKT cells are activated by lipoprotein
PAMPs presented by CD1 receptors (Rossjohn et al., 2012). B1
lymphocytes are frequently poly-specifics and seem to be selected
to recognize both self-antigens and PAMPs (Baumgarth, 2011).
Trained Immunity
Until less than a decade ago, there was a general assumption
that the B and T lymphocytes of the adaptive immune system
were the only components able to generate memory cells, and
mount recall memory responses (Murphy et al., 2008). Several
recent studies have challenged this dogma (reviewed in Netea
et al., 2011; Min-Oo et al., 2013; Martin, 2014), suggesting that
the innate immune system displays adaptive properties. Natural
Killer (NK) cells (that do not express specific antigen receptors)
can autonomously retain a memory of past antigen encounters
and mediate more robust secondary responses (Cooper et al.,
2009). In some cases, protection has been associated with
the clonal expansion of NK cells (Keppel et al., 2013). Until
now, it has not been clear whether the functional antigen
specificity of NK memory is comparable to that of T and
B lymphocyte-mediated memory. Several studies also provide
evidence that monocytes exposed in vivo to pathogens (Quintin
et al., 2012) mount protective recall responses to re-infection,
suggesting that even cells derived from the myeloid lineage
in mammals may possess features of adaptive immunity. This
phenomenon seems to be linked with epigenetic modifications,
as stable histone methylation changes have been observed in the
genome of innate memory cells (Quintin et al., 2012). The term
“trained immunity” has been proposed (Netea et al., 2011) for
the persistent enhanced state of the innate immune response
following exposure to certain infectious agents, which may result
in increased resistance to related or unrelated pathogens. As
expected, a part of the cross-protection induced by vaccines
seems to be dependent on trained immunity (reviewed in Blok
et al., 2015). Interestingly, although only recently described,
this phenomenon seems to be very common among living
organisms. Plants, which possess only an innate immune system,
also display an enhanced state of resistance and faster and
stronger responses following infection (Fu and Dong, 2013).
The underlying mechanisms seem also to include epigenetic
modifications.
The mechanisms explaining cross-protective immunity are
not limited to poly-specificity of lymphocytes, the Mackaness
reaction, trained immunity, or microbiota-mediated protection.
Infection can durably remodel mucosal tissues, thus favoring
or impairing immune responses against unrelated pathogens
(reviewed in Didierlaurent et al., 2007; Foo and Phipps,
2010). For example, in the lung, successive infections modify
epithelium adherence and change the lymphatic network and
the frequency of inducible bronchus-associated lymphoid tissue
(iBALT). In addition, it would be wise to consider each
infection as a unique phenomenon, as each pathogen displays
particular immune escape mechanisms directly affecting the
immune system. For example, a recent study (Mina et al.,
2015) has demonstrated that a large part of nonspecific measles
vaccine benefits come from the ability of the vaccine to impair
measles-induced immune suppression characterized by systemic
depletion of lymphocytes and reduced innate immune cell
proliferation. By preventingmeasles-associated immunememory
loss, measles vaccination also induces polymicrobial herd
immunity.
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A NEW COMPLEX ECOLOGICAL
PARADIGM OF IMMUNITY EMERGES
The Immune System: A Nonlinear,
Interactive, and Evolving Network
Viewed as a whole, previous data support the idea that a
non-negligible part of AIID is nonspecific to the antigens
expressed by pathogens and is dependent on the past and present
interactions of the host immune system with its environment.
The ecological vision of the host protective immune response
as dependent on multiple environmental factors is not new. In
1966, Fazekas de St Groth et al. already wrote that “Response
to vaccine depends not only on the nature of the antigen
itself but also on the immunological history of the recipient”
and introduced the phenomenon of “original antigenic sin”
to describe the inability of an experimented immune system
to produce antibodies in response to a new antigen (Fazekas
de St Groth Webster, 1966). In the same way, the “hygiene
hypothesis” was proposed by Strachan (1989) to explain the
rapid rise of asthma during the twentieth century. The original
formulation of the hygiene hypothesis states that a lower
incidence of infection in early childhood could affect the
maturation of immune responses and favor the development
of allergic diseases. During the last decade, this hypothesis
has been progressively extended (Oikonomopoulou et al.,
2013) to the development of autoimmune diseases and cancer,
popularizing the idea that immune responses against pathogens,
allergens, or tumors can influence each other nonlinearly. If
we accept that immune cross-protection is more common in
nature than previously expected, we can no longer look at
vaccination or infection events independently of each other.
Experimental and epidemiologic studies on cross-protection
suggest that memory lymphocytes do not form fixed and
isolated clusters of cells but rather an interactive and evolving
cell nonlinear network displaying the properties of “adaptive
complex systems” (CASs) (Holland, 2006; Brownlee, 2007)
described in systems biology. CASs are open and dynamic
nonlinear networks of interdependent agents, constantly acting
and reacting to what the other agents are doing and to
forces external to the system. As a result of these permanent
complex interactions, CASs exist in a state of dynamic flux and
change constantly and discontinuously. Antigenic challenge can
alter the reactivity of the immune network by modifying the
frequency of T and B lymphocytes and their polarization. The
trained immunity phenomenon suggests that the innate immune
system can also participate in this network, memorize past
experiments and durably affect the polarization and reactivity of
lymphocytes.
The Microbiota and Pathogens form
Integral Parts of the Host Immune System
Mounting evidence supports the view that eukaryotic hosts and
their microbiota have co-evolved toward mutualistic interactions
benefiting each partner. This vision suggests that the microbiota
and the host form a superorganism (Eberl, 2010) (also termed
metaorganism; Bosch andMcFall-Ngai, 2011) where the immune
system plays not a “military role” (fighting well defined enemies)
but a “police role” (penalizing parasitic/selfish comportments)
to shape homeostasis within this consortium (Muraille, 2013).
As previously discussed, the microbiota plays undeniable direct
and indirect roles in the control of infectious microorganisms
(Ivanov et al., 2009; Buffie and Pamer, 2013; Kamada et al.,
2013). However, the distinction between the microbiota and
pathogens is artificial and confusing as colonization by
“pathogenic” bacteria or viral species is very frequent under
healthy circumstances. For example, Streptococcus pneumoniae,
H. influenzae, and S. aureus are commonly found in the
respiratory tract of healthy individuals (reviewed in Bosch
et al., 2013) and are considered as pathobionts (i.e., potentially
pathological organisms which, under normal circumstances, live
like commensals). In several infectious models (Belkaid et al.,
2002; Obar et al., 2006; Beura et al., 2015), persisting pathogens
have been described to enhance T cell memory and assure
protection against secondary infection (via the concomitant
immunity phenomenon). By inducing a cross-reactive repertoire,
the Mackaness reaction or trained immunity, the pathogens can
frequently participate in protection of the host against unrelated
infectious diseases. These observations have prompted me to
propose that the concept of the microbiota as forming an integral
part of the host immune system (Kitano and Oda, 2006; Cerf-
Bensussan and Gaboriau-Routhiau, 2010) should logically be
extended to pathogens. The host, its specific microbiota and
the infecting microrganisms are interdependent and form a
highly interactive network. Considering each part independently
of the others is a reductionist view that has led us to neglect
numerous important natural phenomena such as nonspecific
AIID.
Some immunologists are still reluctant to admit the possibility
of a nonspecific side of AIID. All immunological textbooks
cite “specificity” as a hallmark of the adaptive immune
response. In fact, this paradigm derives mainly from the use
of simple proteins, such as ovalbumin, to study adaptive
response. The administration of simple proteins in an inbred
naive mice model induces a highly reproducible, and thus
predictable, immune response. Retrospectively, this approach,
through successful, appears to be questionable. First of all,
this type of antigen does not naturally induce an immune
response. Single proteins generally need to be associated with
an adjuvant, the “immunologist’s dirty little secret” as termed by
Janeway (1989), to induce the inflammatory reaction required
for lymphocyte activation. Under natural conditions, the reaction
to a simple, non-proliferating, and non-damaging molecule
is a trait of an allergic or autoimmune reaction and is
generally not associated with a protective immune reaction.
Second, pathogens are not simple structures and their antigen
composition is very complex and fluctuates widely. This feature
is frequently underestimated as immunologists generally neglect
the intra-species diversity of pathogens and their “within host
evolution” during chronic infection (Pybus and Rambaut, 2009;
Wilson, 2012). Small RNA viruses such as HIV are a well-
documented example of this. These viruses express a limited
number of genes, but produce, within a very short period
of time, an extraordinarily high number of variants in the
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host, thereby generating a dynamic heterogeneous population
(termed quasi-species or cloud) with high antigen complexity
(Domingo et al., 2012). Similarly, bacteria can display great
diversity in the host, rapidly evolve within it (Shin et al.,
2004; Hoboth et al., 2009) and follow a complex cycle (Justice
et al., 2004). This structural complexity is conducive to the
sharing of antigenic determinants between pathogens and the
probability of cross-immune reactions. Lastly, in contrast to
inbred naive mice, the variability of the adaptive immune
response of individuals in nature is non negligible, even
against simple proteins. This characteristic is notably due to
the initial variability of the adaptive immune repertoire, as
described in Oudin’s seminal work on idiotypy in the rabbit
in 1969 (Oudin and Michel, 1969), and to the individual’s
immune history which shapes the BCR and TCR repertoire.
Thus, a large part of the apparent specificity of the adaptive
immune response derives from the systematic use of highly
reductionist experimental models selected by experimenters for
their reproducibility and predictability. This conclusion should
not be seen as a general challenge of the reductionist approach
that is an inevitable stage in biological research, but as a
reminder that our perception of reality results from the way
in which we study it. We must constantly ask ourselves what
we are neglecting in our models and whether or not we want
to refine our understanding of reality, as this may affect our
results.
From an evolutionary point of view, it would appear
that the selection of an immune system displaying the
potential to mediate cross-protective reactions is ineluctable to
counter the selective pressure of rapidly adapting pathogens
displaying complex escape immune mechanisms. Antigenic
variation is one of the most common escape strategies of
pathogens. The possibility of antigen-unspecific activation
of immune effectors can potentially offer protection against
new antigenic variants of pathogens. Numerous pathogens
are also able to hide their antigens from the immune
system and induce local anti-inflammatory environments. The
Mackaness effect induced by unrelated infection can allow
for the elimination or control of these stealth pathogens.
Finally, the ability of the individual immune system to
integrate and process all immune experiments results in a
partially unpredictable immune response against infection. This
may have also favored population survival as unpredictable
individual responses promote the diversity of immune responses
inside a population and thereby potential herd immunity
to infection (discussed in Muraille, 2014). Thus, immune
cross-reactions may not be a negligible “by-product” of the
immune system response, but rather one of its fundamental
traits in nature. As each individual initially produces a
private T and B repertoire by random rearrangement of
genes (reviewed in Muraille, 2014) and displays a particular
immune history and a specific microbiota (Monteiro-da-Silva
et al., 2014; Sato et al., 2015), cross-protection appears to
be largely unpredictable at the individual level. However, we
can reasonably expect that a better understanding of the
underlyingmechanisms will allow us to statistically predict cross-
protection at the population level and integrate this phenomenon
into future vaccination strategies. The field of nonspecific
AIID is still in its infancy and needs to be systematically
explored.
PRACTICAL IMPLICATIONS AND
PERSPECTIVES
The paradigm of the antigen specificity of AIID has dominated
the field of immunology for decades. The great majority of
prophylactic and therapeutic immune treatments, such as
subunit vaccines, antigen-specific immunotherapies against
autoimmune diseases, tumors, and allergies, successfully
exploit the specific side of acquired immunity. Acceptance
of the nonspecific side of acquired immunity could have
several important consequences on how we conceive
self-tolerance, vaccination strategies and antitumoral
immunity, and highlight the importance of considering
the microbiota and chronic infectious pathogens as part
of the host defense system against infection under natural
conditions.
Revisiting the Theory of Immune Tolerance
If a natural infection were to lead to an increased frequency
of lymphocytes displaying a large range of reactivities, cross-
reaction with a self-antigen would become frequent and
inevitable. This would also mean that the pre-immune repertoire
of experienced healthy individuals should display high-
affinity antigen receptors specific for self-determinants. This
phenomenon has been documented in healthy mice and
humans (Avrameas et al., 2007; Nagele et al., 2013), but
remains unexplained using the classical paradigms of tolerance.
Classical self-tolerance theories propose that the choice of the
immune system to tolerate or reject is based on the detection
of a “simple” qualitative signal such as a microbial signature
(stranger/pattern recognition theory; Janeway, 1989), damage
signatures (danger theory; Matzinger, 2002), or more recently
an abrupt discontinuity of the antigen signal (discontinuity
theory; Pradeu et al., 2013) (Figure 2A). However, this approach
does not take into consideration the connection between the
components of the immune system and more particularly the
highly interconnected network of the many innate and adaptive
immune detectors. As discussed by Kitano (Kitano and Oda,
2006; Oda and Kitano, 2006), some parts of the immune network
display a characteristic “bow tie” architecture (Figure 2B).
Typically, this type of architecture detects a wide range of
inputs through a degenerate detection system coupled to a
“central processing unit” (conserved core), where the inputs
are organized and processed. In turn, this system can provide
a large variety of responses leading to non-trivial (unreliable,
partially unpredictable) causal action (reviewed in Tieri et al.,
2010). This suggests that immune tolerance could be the result
of an elaborate computation by the immune network based
on a very large set of parameters including microbial and
damage signatures, but also a great number of other contextual
parameters such as the location and duration of antigenic
signals, the individual immune history and the general state
of the host organism. In other terms, the immune network
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FIGURE 2 | Comparison of (A) “classical” and (B) “bow tie” tolerance theories.
could acts as a “cognition system,” like the central nervous
system, and be capable of information processing, learning,
memorization, and adaptation. From this perspective, tolerance
results from the interpretation of multiple signals in a general
context. Of course, this does not mean that all signals have the
same value. The immune system can focus on some signals,
such as PAMPs or DAMPs, but the decision process remains
dependant on the general context and requires information
processing. This “bow tie hypothesis” fits with my proposal
(Muraille, 2013) that the immune system was initially selected
during evolution to allow for cooperation with the microbiota
by tolerating cooperative and fighting selfish/cheater partners.
It seems evident that endogenous (tumors) or exogenous
(microbial pathogens) cheaters cannot be identified as such
based only on a predefined signature, but on the evaluation of
context-dependent behavior. This analysis requires an elaborate
computation process and is indispensable to adapt to an
evolving and unpredictable antigenic environment as well as to
discriminate between noise and significant signals. In summary,
the bow tie hypothesis suggests that a better understanding
of tolerance can only come from a holistic approach to
processing information networks within the immune system.
In contrast, previous theories on tolerance propose mainly to
focus research on the identification of specific signals (PAMPs,
DAMP, etc.) supposed to regulate the tolerance process directly
(linearly).
Vaccination Strategies
Historically, the great success of vaccination campaigns has been
associated with the administration of live-attenuated vaccines,
such as Jenner’s smallpox vaccine, the Bacillus Calmette–Guérin
(BCG) vaccine, Sabin’s polio vaccine and Hilleman’s measles,
mumps, and rubella vaccine. As previously discussed, these
vaccines could display important non antigen-specific protective
effects dependent on the innate or adaptive immune system.
Thus, some of these vaccines could have important beneficial
effects on populations even if their respective target diseases
have been eliminated. For example, several epidemiological
studies (Aaby et al., 2006; Jensen et al., 2006; Sørup et al.,
2011) showed that smallpox-vaccinated individuals are at a
lower risk of hospitalization for most subgroups of infectious
diseases when compared to individuals not vaccinated for
smallpox. As a result, it may be important to quantify the
nonspecific beneficial effects associated with each vaccine before
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restricting their use. Modern vaccination strategies focus on
the use of “adjuvanted” subunit vaccines (Pérez et al., 2013;
Reed et al., 2013; De Gregorio and Rappuoli, 2014) that drive
immune responses against dominant antigens expressed with
low variability by pathogens. When compared to live-attenuated
vaccines, there are several strong arguments in favor of subunit
vaccines: (i) their supposed safety because they exclude all risks
of reversion of attenuated pathogens to a virulent form, (ii)
their high specificity limiting the risk of autoimmune diseases,
and (iii) the difficulty to cultivate, conserve and transport live
vaccines. However, the ability of adjuvanted subunit vaccines
to induce trained immunity and cross-reactive lymphocytes is
poorly documented. Modern synthetic adjuvants are first of
all selected for their low inflammatory potential and it is not
sure that they stimulate innate immunity that is strong enough
and long enough to induce trained immunity. It could be
interesting to systematically investigate the ability of synthetic
adjuvants to induce trained immunity. Subunit vaccine strategies
generally target a reduced number of antigenic structures and
limit cross reactivity, thereby completely neglecting the adaptive
capacity of pathogens. Indeed, microbial pathogens frequently
display a very complex and fluctuating antigen composition. In
addition to presenting important intra-species diversity, they
show “within host evolution” during chronic infection (Pybus
and Rambaut, 2009; Wilson, 2012). Small RNA viruses such
as HIV are a well-documented example of this. These viruses
express a limited number of genes but produce, in a very short
period of time, an extraordinarily high number of variants
in the host, generating a dynamic heterogeneous population
(termed quasi-species or cloud) with high antigen complexity
(Domingo et al., 2012). Similarly, bacteria can display great
diversity in the host and rapidly evolve within it (Shin et al.,
2004; Hoboth et al., 2009). A stable specific selective pressure
is unable to control rapidly evolving pathogens for long. This
could explain why subunit vaccine strategies have failed for
decades to control numerous pandemics such as those associated
with HIV, tuberculosis and malaria. In comparison, live vaccines
display wide coverage against a multiplicity of antigens and
are able to better cope with pathogen strain polymorphisms
and host genetic restrictions. Thus, rational replacement of
old vaccines with modern versions should be based on the
assessment of both the specific and nonspecific benefits of each
vaccine. A better understanding and exploitation of the cross-
protection conferred by vaccines could open up new avenues
in vaccine research, particularly in the development of multi-
or poly-reactive vaccines. Along these lines, the World Health
Organization recognized the importance of the nonspecific
effects of vaccines in April 2014 and recommended further
research in this new direction (World Health Organization,
2014).
Manipulation of the Microbiota
Modification of the microbiota composition by probiotics
(Alexandre et al., 2014) and microbiota transfer (Austin
et al., 2014) can constitute a powerful and not yet fully
explored strategy to prevent or fight infection with
multiresistant or highly-variable pathogens that escape
classical antibiotic therapies or vaccination. For example,
recent work on Plasmodium infection revealed that the
host’s microbiota plays an important role in the control of
malaria (Yilmaz et al., 2014). The authors demonstrated
that both Plasmodium spp. and the human gut pathobiont
Escherichia coli O86:B7 express α-gal, and that anti-α-gal
antibodies are associated with protection against malaria
transmission in humans, suggesting that gut probiotics could
represent innovative tools for malaria prevention. Thus, a
single α-gal displayed by a bacterium can affect resistance
to a protozoon. This is yet another perfect demonstration
that acquired resistance to infection can be nonspecific to
the pathogen encountered. In the same way, therapeutic
use of lytic bacteriophages (O’Flaherty et al., 2009) or
predatory bacteria (Allen et al., 2014) to treat pathogenic
bacterial infections is one approach that has great potential
as a solution to the serious worldwide problem of drug-
resistant bacteria. In addition to offering an alternative
solution to antibiotics, these therapies allow for more selective
elimination of pathogenic bacteria without deeply affecting
the host microbiota and reducing its resistance to opportunist
infection.
Nonspecific Immune Control of Tumors
Despite considerable progress in cancer genetics, the vast
majority ofmetastatic solid tumors still remain incurable today. It
has become clear that tumors are heterogeneous structures that,
during development and growth, become “sculpted” or “edited”
by immune responses and, as a result, pass through the “three E’s”
of elimination, equilibration and escape (reviewed in Gerlinger
et al., 2014). This Darwinian evolution of tumors within
hosts explains the short-lived effects of immunotherapeutic
strategies based on one single or a few tumor antigens and
the difficulty to identify biomarkers common to large groups
of tumors. Genetically distinct subpopulations of tumor cells
have also been observed to cooperate to promote tumor
growth, progression, and maintenance (Gerlinger et al., 2014).
Interestingly, epidemiological studies have clearly established
an inverse relationship between acute infections and cancer
development (Rastogi et al., 2008; Krone et al., 2014).
Spontaneous tumor regression has been observed in association
with a wide range of infectious organisms including those
of bacterial, fungal, viral, and protozoal origin (Reilly and
Christine, 1953; Oliveira et al., 2001; Rosenberg et al., 2002;
Baird et al., 2013). Not all types of microorganisms are expected
to have the same anticarcinogenic effect; for example, viral
infections seem to be mainly procarcinogenic, in contrast
to bacteria or parasitic worms that more frequently exhibit
antitumorigenic effects. In contrast to acute infections, chronic
infections can be viewed as resulting from a failed immune
response and an increasing number have been associated
with an elevated risk of cancer (Hoption Cann et al., 2006).
There are scores of ways in which infectious diseases can
alter the course of cancers, and this should remain an area
of intense study. Once again, in contrast to the classical
specific approach focusing on the identification of specific
tumor antigens, a promising focus of research could be
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based on exploitation of the nonspecific protective effect
of the pathogen-induced immune response. Indeed, several
experimental studies (reviewed in Bolhassani and Zahedifard,
2012) suggest that at least some pathogens and live vaccines
may be beneficial with respect to the subsequent risk of
cancer.
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